These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31246349)

  • 1. PSICA: Decision trees for probabilistic subgroup identification with categorical treatments.
    Sysoev O; Bartoszek K; Ekström EC; Ekholm Selling K
    Stat Med; 2019 Sep; 38(22):4436-4452. PubMed ID: 31246349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ensemble survival trees for identifying subpopulations in personalized medicine.
    Chen YC; Chen JJ
    Biom J; 2016 Sep; 58(5):1151-63. PubMed ID: 27073016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations.
    Huber C; Benda N; Friede T
    Pharm Stat; 2019 Oct; 18(5):600-626. PubMed ID: 31270933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating effectiveness of subgroup identification for longitudinal data.
    Andrews N; Cho H
    Stat Med; 2018 Jan; 37(1):98-106. PubMed ID: 28948635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplicity-adjusted semiparametric benefiting subgroup identification in clinical trials.
    Schnell PM; Müller P; Tang Q; Carlin BP
    Clin Trials; 2018 Feb; 15(1):75-86. PubMed ID: 29035083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Algorithm for Generating Individualized Treatment Decision Trees and Random Forests.
    Doubleday K; Zhou H; Fu H; Zhou J
    J Comput Graph Stat; 2018; 27(4):849-860. PubMed ID: 32523325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk controlled decision trees and random forests for precision Medicine.
    Doubleday K; Zhou J; Zhou H; Fu H
    Stat Med; 2022 Feb; 41(4):719-735. PubMed ID: 34786731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depth importance in precision medicine (DIPM): a tree- and forest-based method for right-censored survival outcomes.
    Chen V; Zhang H
    Biostatistics; 2022 Jan; 23(1):157-172. PubMed ID: 32424406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative interaction trees: a tool to identify qualitative treatment-subgroup interactions.
    Dusseldorp E; Van Mechelen I
    Stat Med; 2014 Jan; 33(2):219-37. PubMed ID: 23922224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival data.
    Zhang P; Ma J; Chen X; Shentu Y
    Stat Med; 2020 Dec; 39(28):4133-4146. PubMed ID: 32786155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAPITAL: Optimal subgroup identification via constrained policy tree search.
    Cai H; Lu W; Marceau West R; Mehrotra DV; Huang L
    Stat Med; 2022 Sep; 41(21):4227-4244. PubMed ID: 35799329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iterative Causal Forest: A Novel Algorithm for Subgroup Identification.
    Wang T; Keil AP; Kim S; Wyss R; Htoo PT; Funk MJ; Buse JB; Kosorok MR; Stürmer T
    Am J Epidemiol; 2024 May; 193(5):764-776. PubMed ID: 37943684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian additive decision trees of biomarker by treatment interactions for predictive biomarker detection and subgroup identification.
    Zhao Y; Zheng W; Zhuo DY; Lu Y; Ma X; Liu H; Zeng Z; Laird G
    J Biopharm Stat; 2018; 28(3):534-549. PubMed ID: 29020511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MediBoost: a Patient Stratification Tool for Interpretable Decision Making in the Era of Precision Medicine.
    Valdes G; Luna JM; Eaton E; Simone CB; Ungar LH; Solberg TD
    Sci Rep; 2016 Nov; 6():37854. PubMed ID: 27901055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine: Subgroup identification in longitudinal trajectories.
    Wei Y; Liu L; Su X; Zhao L; Jiang H
    Stat Methods Med Res; 2020 Sep; 29(9):2603-2616. PubMed ID: 32070237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subgroup identification for treatment selection in biomarker adaptive design.
    Lu TP; Chen JJ
    BMC Med Res Methodol; 2015 Dec; 15():105. PubMed ID: 26646831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subgroup identification in dose-finding trials via model-based recursive partitioning.
    Thomas M; Bornkamp B; Seibold H
    Stat Med; 2018 May; 37(10):1608-1624. PubMed ID: 29388228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized Risk Prediction in Clinical Oncology Research: Applications and Practical Issues Using Survival Trees and Random Forests.
    Hu C; Steingrimsson JA
    J Biopharm Stat; 2018; 28(2):333-349. PubMed ID: 29048993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted Bootstrap.
    Shen J; Wang L; Daignault S; Spratt DE; Morgan TM; Taylor JMG
    J Biopharm Stat; 2018; 28(2):362-381. PubMed ID: 28934002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Look before you leap: systematic evaluation of tree-based statistical methods in subgroup identification.
    Liu Y; Ma X; Zhang D; Geng L; Wang X; Zheng W; Chen MH
    J Biopharm Stat; 2019; 29(6):1082-1102. PubMed ID: 30859903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.